| scholarly article | Q13442814 |
| P2093 | author name string | Gang Lu | |
| Muhammad Ashraf | |||
| Linlin Wang | |||
| Husnain Kh Haider | |||
| Longhu Li | |||
| P2860 | cites work | Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty | Q74190220 |
| Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling | Q83323467 | ||
| Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase | Q24336601 | ||
| Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use | Q28263273 | ||
| cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes | Q28577644 | ||
| Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling | Q29615163 | ||
| Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway | Q30273656 | ||
| Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice | Q30548444 | ||
| Apoptosis: the germs of death | Q33772652 | ||
| Cyclic nucleotide phosphodiesterases: relating structure and function | Q34047795 | ||
| Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells | Q34357737 | ||
| Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide | Q34503391 | ||
| Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways | Q34530552 | ||
| Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases | Q34599923 | ||
| The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice | Q35015659 | ||
| Phosphodiesterase type 5 and high altitude pulmonary hypertension. | Q35537900 | ||
| Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension | Q36203104 | ||
| Navigating the crossroads of coronary artery disease and heart failure. | Q36591047 | ||
| Overview of PDEs and their regulation | Q36739122 | ||
| Cardiovascular cGMP-generating systems in physiological and pathological conditions. | Q36754532 | ||
| Phosphodiesterase regulation of nitric oxide signaling | Q36805849 | ||
| Short hairpin RNA interference therapy for ischemic heart disease | Q36853941 | ||
| Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes | Q37012737 | ||
| Phosphodiesterase type 5: expanding roles in cardiovascular regulation | Q37015149 | ||
| Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury | Q37264402 | ||
| Modulation of cGMP in heart failure: a new therapeutic paradigm | Q37329891 | ||
| Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). | Q38336160 | ||
| Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo | Q40157495 | ||
| Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle | Q41265653 | ||
| Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure | Q42507993 | ||
| Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. | Q44907848 | ||
| Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice | Q44935527 | ||
| Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy | Q45235067 | ||
| Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction | Q45887723 | ||
| Developmental changes in the delayed rectifier K+ channels in mouse heart. | Q52200708 | ||
| Signal transduction by cGMP in heart. | Q54759025 | ||
| Long-Term Trends in the Incidence of and Survival with Heart Failure | Q57073236 | ||
| Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators | Q72932823 | ||
| P433 | issue | 10 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | H2112-21 | |
| P577 | publication date | 2012-03-23 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction | |
| P478 | volume | 302 |
| Q36128551 | Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials |
| Q38191440 | Exercise training in adverse cardiac remodeling |
| Q35879351 | Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory Cytokines |
| Q34639920 | Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction |
| Q45354313 | Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair |
Search more.